Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy
Endoscopy International Open · 01.05.2023 · 11 (05) · E490-E496
DOI: 10.1055/a-2048-2279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 01.05.2023. Verfasst von Beatriz Sicilia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario de Burgos, Burgos, Spain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims Rates of new dysplastic lesions or cancer progression after first dye chromoendoscopy in the era of high-definition endoscopy have yet to be determined. Patients and methods A multicenter, population-based, retrospective cohort study was performed in seven hospitals in Spain. Patients with inflammatory bowel disease and fully resected (R0) dysplastic colon lesions under surveillance with high-definition dye-based chromoendoscopy were sequentially enrolled between February 2011 and June 2017, with a minimum endoscopic follow-up of 36 months. The aim was to assess the incidence of developing more advanced metachronous neoplasia by analyzing possible associated risk factors.
Results
The study sample included 99 patients and 148 index lesions (145 low-grade dysplasia lesions and three high-grade dysplasia [HGD] lesions with a mean follow-up of 48.76 months [IQR: 36.34–67.15]). The overall incidence of new dysplastic lesions was 0.23 per 100 patient-years, 1.15 per 100 patients at 5 years and 2.29 per 100 patients at 10 years. A history of dysplasia was associated with a higher risk of developing any grade of dysplasia during follow-up (P = 0.025), whereas left colon lesions were associated with a lower risk (P = 0.043). The incidence of more advanced lesions at 1 year and 10 years was 1 % and 14 % respectively, with lesion size > 1 cm being a risk factor (P = 0.041). One of the eight patients (13 %) with HGD lesions developed colorectal cancer during follow-up.
Conclusions
The risk of dysplasia progressing to advanced neoplasia and, specifically, the risk of new neoplastic lesions after endoscopic resection of colitis-associated dysplasia, are both very low.
Autor:innen und Institutionen
- Hospital Universitario de Burgos, Burgos, Spain.
- Puerta de Hierro Hospital, Majadahonda, Spain.
- Hospital clínico universitario Valladolid Valladolid, Spain.
- Complejo asistencial de León, León, Spain.
- Hospital Universitario Rio Hortega Valladolid, Valladolid, Spain.
- Hospital universitario de Salamanca, Salamanca, Spain.
ORCID-Profile: Beatriz Sicilia, Luis Hernández
Zitieren
APA
Sicilia, B., González-Lama, Y., Velayos, B., Suárez, P., Maroto-Martín, C., Nuñez, A., Hernández, L., Sáiz-Chumillas, R. M., Relea, L., Fernández-Salazar, L., Sierra-Ausín, M., Barrio Andrés, J., Muñoz, F., & Arias García, L. (2023). Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy. Endoscopy International Open, 11(05), E490-E496. https://doi.org/10.1055/a-2048-2279
Vancouver
Sicilia B, González-Lama Y, Velayos B, Suárez P, Maroto-Martín C, Nuñez A, et al. Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy. Endoscopy International Open. 2023;11(05):E490-E496. doi:10.1055/a-2048-2279
BibTeX
@article{Sicilia2023,
author = {Sicilia, Beatriz and González-Lama, Yago and Velayos, Benito and Suárez, Patricia and Maroto-Martín, Carlos and Nuñez, Aljandro and Hernández, Luis and Sáiz-Chumillas, Rosa M and Relea, Lucia and Fernández-Salazar, Luis and Sierra-Ausín, Mónica and Barrio Andrés, Jesús and Muñoz, Fernando and Arias García, Lara},
title = {Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy},
journal = {Endoscopy International Open},
year = {2023},
volume = {11},
number = {05},
pages = {E490--E496},
doi = {10.1055/a-2048-2279}
}
EUVIMED